Susan Smith (Former Employee)
Science and Products
Moderate susceptibility to subcutaneous plague (Yersinia pestis) challenge in vaccine-treated and untreated Sonoran deer mice (Peromyscus maniculatus sonoriensis) and northern grasshopper mice (Onychomys leucogaster)
The variable response of wild mice to Yersinia pestis infection, the causative agent of plague, has generated much speculation concerning their role in the ecology of this potentially lethal disease. Researchers have questioned the means by which Y. pestis is maintained in nature and also sought methods for managing the disease. Here we assessed the efficacy of a new tool, the sylvatic plague vacc
Authors
Gebbiena Bron, Susan Smith, Judy L. Williamson, Daniel W. Tripp, Tonie E. Rocke
VNTR diversity in Yersinia pestis isolates from an animal challenge study reveals the potential for in vitro mutations during laboratory cultivation
Underlying mutation rates and other evolutionary forces shape the population structure of bacteria in nature. Although easily overlooked, similar forces are at work in the laboratory and may influence observed mutations. Here, we investigated tissue samples and Yersinia pestis isolates from a rodent laboratory challenge with strain CO92 using whole genome sequencing and multi-locus variable-number
Authors
Amy J. Vogler, Roxanne Nottingham, Joseph D. Busch, Jason W. Sahl, Megan M. Shuey, Jeffrey T. Foster, James M. Schupp, Susan Smith, Tonie E. Rocke, Paul Klein, David M. Wagner
Age at vaccination may influence response to sylvatic plague vaccine (SPV) in Gunnison’s prairie dogs (Cynomys gunnisoni)
Gunnison’s prairie dogs (Cynomys gunnisoni) have been considered at greater risk from Yersinia pestis (plague) infection in the montane portion of their range compared to populations at lower elevations, possibly due to factors related to flea transmission of the bacteria or greater host susceptibility. To test the latter hypothesis and determine whether vaccination against plague with an oral syl
Authors
Tonie E. Rocke, Daniel W. Tripp, Faye Lorenzsonn, Elizabeth A. Falendysz, Susan Smith, Judy L. Williamson, Rachel C. Abbott
Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus)
Baits containing recombinant raccoon poxvirus (RCN) expressing plague antigens (fraction 1 [F1] and a truncated form of the V protein-V307) were offered for voluntary consumption several times over the course of several months to a group of 16 black-tailed prairie dogs (Cynomys ludovicianus). For comparison, another group of prairie dogs (n = 12) was injected subcutaneously (SC) (prime and boost)
Authors
Tonie E. Rocke, Nicola Pussini, Susan Smith, Judy L. Williamson, Bradford Powell, Jorge E. Osorio
Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
In previous studies, we demonstrated protection against plague in mice and prairie dogs using a raccoon pox (RCN) virus-vectored vaccine that expressed the F1 capsular antigen of Yersinia pestis. In order to improve vaccine efficacy, we have now constructed additional RCN-plague vaccines containing two different forms of the lcrV (V) gene, including full-length (Vfull) and a truncated form (V307).
Authors
Tonie E. Rocke, Keith P. Iams, S. Dawe, Susan Smith, Judy L. Williamson, Dennis M. Heisey, Jorge E. Osorio
Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits
Prairie dogs (Cynomys spp.) are highly susceptible to Yersinia pestis and, along with other wild rodents, are significant reservoirs of plague for other wildlife and humans in the western United States. A recombinant raccoon poxvirus, expressing the F1 antigen of Y. pestis, was incorporated into a palatable bait and offered to three groups (n=18, 19, and 20) of black-tailed prairie dogs (Cynomys l
Authors
Tonie E. Rocke, Susan Smith, D.T. Stinchcomb, Jorge E. Osorio
Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis
Previous studies have established that vaccination of black-footed ferrets (Mustela nigripes) with F1-V fusion protein by subcutaneous (SC) injection protects the animals against plague upon injection of the bacterium Yersinia pestis. This study demonstrates that the F1-V antigen can also protect ferrets against plague contracted via ingestion of a Y. pestis-infected mouse, a probable route for na
Authors
Tonie E. Rocke, Susan Smith, Paul E. Marinari, J. Kreeger, J.T. Enama, B.S. Powell
Toxicoinfectious botulism in commercial caponized chickens
During the summer of 2003, two flocks of commercial broiler chickens experienced unusually high death losses following caponizing at 3 wk of age and again between 8 and 14 wk of age. In September, fifteen 11-wk-old live capons were submitted to the Iowa State University Veterinary Diagnostic Laboratory for assistance. In both flocks, the second episode of elevated mortality was associated with inc
Authors
D.W. Trampel, Susan Smith, Tonie E. Rocke
Recombinant F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against virulent Yersinia pestis infection
Black-footed ferrets (Mustela nigripes) are highly susceptible to sylvatic plague, caused by the bacterium Yersinia pestis, and this disease has severely hampered efforts to restore ferrets to their historic range. A study was conducted to assess the efficacy of vaccination of black-footed ferrets against plague using a recombinant protein vaccine, designated F1-V, developed by personnel at the U.
Authors
Tonie E. Rocke, J. Mencher, Susan Smith, A. M. Friedlander, G.P. Andrews, L. A. Baeten
Preliminary evaluation of a simple in vitro test for the diagnosis of type C botulism in wild birds
An enzyme-linked immunosorbent assay (ELISA) was developed for the detection of type C botulinum toxin (Clostridium botulinum) in wild birds. This simple, antigen-capture ELISA utilizes polystyrene immunosticks as the solid substrate, chicken antitoxin (IgY) as the coating antibody, rabbit antitoxin as the primary antibody, and peroxidase-labeled goat-anti-rabbit as the secondary antibody. To eval
Authors
Tonie E. Rocke, Susan Smith, Sean Nashold
Science and Products
Moderate susceptibility to subcutaneous plague (Yersinia pestis) challenge in vaccine-treated and untreated Sonoran deer mice (Peromyscus maniculatus sonoriensis) and northern grasshopper mice (Onychomys leucogaster)
The variable response of wild mice to Yersinia pestis infection, the causative agent of plague, has generated much speculation concerning their role in the ecology of this potentially lethal disease. Researchers have questioned the means by which Y. pestis is maintained in nature and also sought methods for managing the disease. Here we assessed the efficacy of a new tool, the sylvatic plague vacc
Authors
Gebbiena Bron, Susan Smith, Judy L. Williamson, Daniel W. Tripp, Tonie E. Rocke
VNTR diversity in Yersinia pestis isolates from an animal challenge study reveals the potential for in vitro mutations during laboratory cultivation
Underlying mutation rates and other evolutionary forces shape the population structure of bacteria in nature. Although easily overlooked, similar forces are at work in the laboratory and may influence observed mutations. Here, we investigated tissue samples and Yersinia pestis isolates from a rodent laboratory challenge with strain CO92 using whole genome sequencing and multi-locus variable-number
Authors
Amy J. Vogler, Roxanne Nottingham, Joseph D. Busch, Jason W. Sahl, Megan M. Shuey, Jeffrey T. Foster, James M. Schupp, Susan Smith, Tonie E. Rocke, Paul Klein, David M. Wagner
Age at vaccination may influence response to sylvatic plague vaccine (SPV) in Gunnison’s prairie dogs (Cynomys gunnisoni)
Gunnison’s prairie dogs (Cynomys gunnisoni) have been considered at greater risk from Yersinia pestis (plague) infection in the montane portion of their range compared to populations at lower elevations, possibly due to factors related to flea transmission of the bacteria or greater host susceptibility. To test the latter hypothesis and determine whether vaccination against plague with an oral syl
Authors
Tonie E. Rocke, Daniel W. Tripp, Faye Lorenzsonn, Elizabeth A. Falendysz, Susan Smith, Judy L. Williamson, Rachel C. Abbott
Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus)
Baits containing recombinant raccoon poxvirus (RCN) expressing plague antigens (fraction 1 [F1] and a truncated form of the V protein-V307) were offered for voluntary consumption several times over the course of several months to a group of 16 black-tailed prairie dogs (Cynomys ludovicianus). For comparison, another group of prairie dogs (n = 12) was injected subcutaneously (SC) (prime and boost)
Authors
Tonie E. Rocke, Nicola Pussini, Susan Smith, Judy L. Williamson, Bradford Powell, Jorge E. Osorio
Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
In previous studies, we demonstrated protection against plague in mice and prairie dogs using a raccoon pox (RCN) virus-vectored vaccine that expressed the F1 capsular antigen of Yersinia pestis. In order to improve vaccine efficacy, we have now constructed additional RCN-plague vaccines containing two different forms of the lcrV (V) gene, including full-length (Vfull) and a truncated form (V307).
Authors
Tonie E. Rocke, Keith P. Iams, S. Dawe, Susan Smith, Judy L. Williamson, Dennis M. Heisey, Jorge E. Osorio
Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits
Prairie dogs (Cynomys spp.) are highly susceptible to Yersinia pestis and, along with other wild rodents, are significant reservoirs of plague for other wildlife and humans in the western United States. A recombinant raccoon poxvirus, expressing the F1 antigen of Y. pestis, was incorporated into a palatable bait and offered to three groups (n=18, 19, and 20) of black-tailed prairie dogs (Cynomys l
Authors
Tonie E. Rocke, Susan Smith, D.T. Stinchcomb, Jorge E. Osorio
Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis
Previous studies have established that vaccination of black-footed ferrets (Mustela nigripes) with F1-V fusion protein by subcutaneous (SC) injection protects the animals against plague upon injection of the bacterium Yersinia pestis. This study demonstrates that the F1-V antigen can also protect ferrets against plague contracted via ingestion of a Y. pestis-infected mouse, a probable route for na
Authors
Tonie E. Rocke, Susan Smith, Paul E. Marinari, J. Kreeger, J.T. Enama, B.S. Powell
Toxicoinfectious botulism in commercial caponized chickens
During the summer of 2003, two flocks of commercial broiler chickens experienced unusually high death losses following caponizing at 3 wk of age and again between 8 and 14 wk of age. In September, fifteen 11-wk-old live capons were submitted to the Iowa State University Veterinary Diagnostic Laboratory for assistance. In both flocks, the second episode of elevated mortality was associated with inc
Authors
D.W. Trampel, Susan Smith, Tonie E. Rocke
Recombinant F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against virulent Yersinia pestis infection
Black-footed ferrets (Mustela nigripes) are highly susceptible to sylvatic plague, caused by the bacterium Yersinia pestis, and this disease has severely hampered efforts to restore ferrets to their historic range. A study was conducted to assess the efficacy of vaccination of black-footed ferrets against plague using a recombinant protein vaccine, designated F1-V, developed by personnel at the U.
Authors
Tonie E. Rocke, J. Mencher, Susan Smith, A. M. Friedlander, G.P. Andrews, L. A. Baeten
Preliminary evaluation of a simple in vitro test for the diagnosis of type C botulism in wild birds
An enzyme-linked immunosorbent assay (ELISA) was developed for the detection of type C botulinum toxin (Clostridium botulinum) in wild birds. This simple, antigen-capture ELISA utilizes polystyrene immunosticks as the solid substrate, chicken antitoxin (IgY) as the coating antibody, rabbit antitoxin as the primary antibody, and peroxidase-labeled goat-anti-rabbit as the secondary antibody. To eval
Authors
Tonie E. Rocke, Susan Smith, Sean Nashold